Navigation Links
Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
Date:10/29/2009

r 3, VALSTAR(TM) became commercially available for the treatment of a distinct form of bladder cancer. VALSTAR represents a new treatment option for patients who may otherwise have exhausted all other FDA-approved treatment alternatives.

On September 24, Endo announced the final results of a cash tender offer by one of its wholly owned subsidiaries, for any and all outstanding Ledgemont PhaRMA(SM) Secured 16% Notes. This offer resulted in Endo's acquiring $48 million of the $105 million aggregate principal amount that was outstanding and reflects the company's ongoing efforts to manage its capital structure.

Selected Product Review

PAIN PRODUCTS

LIDODERM®: For the quarter ended September 30, 2009, net sales of LIDODERM were $193 million comparable to $194 million in the same period a year ago. For the nine months ended September 30, 2009, net sales of LIDODERM were flat at $560 million compared with $560 million in the same period a year ago.

OPANA® ER and OPANA®: Combined net sales for the OPANA franchise increased 42 percent to $59 million for the third quarter 2009 compared with $41 million in the same period a year ago. For the nine months ended September 30, 2009, combined net sales for the OPANA franchise increased 30 percent to $167 million compared with $128 million in the same period a year ago.

FROVA®: Net sales of FROVA were $15 million for the three months ended September 30, 2009 compared with $14 million for the same period in 2008. Net sales of FROVA were $42 million for the nine months ended September 30, 2009 compared with $41 million for the same period in 2008.

Voltaren® Gel: Net sales of Voltaren Gel were $20 million for the three months ended September 30, 2009 compared with $10 million for the same period in 2008. Net sales of Voltaren Gel were $57 million for the nine months ended Sep
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Dr. Harry Kovelman Joins Ferring Pharmaceuticals as Associate Medical Director for Orthopaedics
2. Transcept Pharmaceuticals Receives Complete Response Letter from FDA on Intermezzo(R) New Drug Application
3. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
4. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
5. DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units
6. Onyx Pharmaceuticals Announces Third Quarter 2009 Financial Results Teleconference and Webcast
7. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
8. Intercept Pharmaceuticals Announces Positive Phase II Results for INT-747 as a Treatment for Primary Biliary Cirrhosis
9. Bellicum Pharmaceuticals Announces $4.5 Million in New Funding
10. BioMarin Acquires Huxley Pharmaceuticals, Inc.
11. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... is pleased to announce the launch of Eyezen ™ ... comes with the constant connection to digital devices. Eyezen ... of glasses to provide comfort and protection for a ... and computers for hours at a time. Eyezen glasses ... also those who currently wear contact lenses or do ...
(Date:9/4/2015)... 4, 2015  PTC Therapeutics, Inc. (NASDAQ: ... of its first-ever global awards program, the STRIVE ... designed to aid nonprofit organizations that are committed ... The announcement is made as the global DMD ... Day on Monday, September 7, 2015. ...
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
Breaking Medicine Technology:Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2
... REDWOOD CITY, Calif., March 19, 2012 Ingenuity Systems, ... life science researchers, today announced that the Weill Cornell ... iReport for use in its sequencing core facility.  Variant ... the output of whole genome and exome sequencing experiments ...
... 19, 2012  Johnson & Johnson (NYSE: JNJ) will provide ... parties on Monday, March 26th at approximately 10:30 ... College of Cardiology (ACC) Annual Scientific Sessions in ... of the EINSTEIN-PE study in treating patients with ...
Cached Medicine Technology:Weill Cornell Medical College Selects Ingenuity® Variant Analysis™ and Ingenuity® iReport™ for Sequencing Core Facility 2
(Date:9/4/2015)... ... September 04, 2015 , ... ... Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and ... rules constantly evolving in the consumer goods industry, it can be difficult for ...
(Date:9/4/2015)... ... September 04, 2015 , ... San ... available at CitiDent. CEREC is a newer method for creating restorations through innovative ... patients by eliminating the need for multiple appointments, CEREC produces restorations with total ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a fresh ... its only mission and research focus: Water Life Science®. In the current warming ... evaporation is becoming dangerously accelerated. As a result of the global fresh water, ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces ... neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. The first ... feature 30 cottage or “pocket” homes. In this community, adults will live safely ...
(Date:9/4/2015)... ... 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written an ... Pope’s upcoming trip to the United States. , Yisrayl lays out what he says is ... and society is. Yisrayl also provides the meaning of his own name and describes what ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... A patients expectations about the side effects of ... other side effects. Worries about severe allergic reactions to ... recent study from the Lineberger Comprehensive Cancer Center at ... Vanderbilt-Ingram Comprehensive Cancer Center and the Sarah Canon Cancer ...
... report says , MONDAY, Aug. 20 (HealthDay News) -- ... not used often enough in the United States, says ... diagnosed with COPD ever received the testing. , ... accepted and encouraged method of diagnosing COPD. ...
... to men of other ethnicities, Tulane University researchers found ... may increase the risk of stroke in Chinese men. ... latest issue of Annals of Neurology. ... School of Public Health and Tropical Medicine recently examined ...
... ethnicities, researchers say , MONDAY, Aug. 20 (HealthDay News) ... men, a new study finds. , The researchers looked of ... history of stroke when first surveyed in 1991. , When ... 2000, researchers found there had been 3,434 strokes and ...
... cardioverter defibrillators (ICDs) are safe and significantly reduce ... (Review, p. 251). In this review of eight ... 76 observational studies that examined safety or effectiveness, ... with left ventricular systolic dysfunction by 20 percent. ...
... in 5 report symptoms of anxiety, depression once back home ... major symptom of post-traumatic stress disorder (PTSD) was reported by ... Force deployed during the Iraq War, says a University of ... conflict. , The women in the survey (74.2 percent enlisted, ...
Cached Medicine News:Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 2Health News:Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US 3Health News:Heavy Drinking Boosts Stroke Risk for Chinese Men 2Health News:Work-Family Conflict Dogs Air Force Women After Deployment 2
... The Biomet Ankle ... ideally suited for,tibiotalocalcaneal ... second-generation nail affords ... fixation that incorporates ...
... clinical and economic issues of cerclage wiring, ... to maximize tension control while minimizing invasion ... efficient instrumentation with a simple technique. , ... indicated for general orthopaedic trauma surgery involving: ...
OmniAccess&trade Hip Retractor System sets a new standard in hip exposure. It provides constant, absolute exposure of the acetabulum during total hip arthroplasty and revision procedures....
... of DePuy's aggressive innovations have become the ... be equalled. The AML Total Hip ... efficiently address and effectively meet the needs ... With greater than 15 years of ...
Medicine Products: